Morita Rena, Hirohashi Yoshihiko, Nakatsugawa Munehide, Kanaseki Takayuki, Torigoe Toshihiko, Sato Noriyuki
Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Methods Mol Biol. 2014;1139:345-55. doi: 10.1007/978-1-4939-0345-0_28.
Identification of antigenic peptides derived from tumor-associated antigens (TAA) enables cancer vaccine therapy using antigenic peptides. Here, we summarize the design of antigenic peptides and induction of cytotoxic T lymphocytes (CTL) using antigenic peptides and validation of CTL.
鉴定源自肿瘤相关抗原(TAA)的抗原肽能够实现使用抗原肽进行癌症疫苗治疗。在此,我们总结抗原肽的设计、使用抗原肽诱导细胞毒性T淋巴细胞(CTL)以及CTL的验证。